is semaglutide on backorder People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and Drug Administration recently Noom to Sell Microdoses of

NAD+ ensures those cells have the energy substrate they need

Both medications carry warnings for potential thyroid tumors (medullary thyroid carcinoma), pancreatitis, kidney disease (including acute kidney injury and worsening kidney disease) and allergic reactions

Talk to your provider about prescribing with us, we look forward to serving you

Excellent product and service

Trial design: 2,339 participants Adults with obesity or overweight + at least one weight-related complication Participants did NOT have diabetes Randomized to placebo or retatrutide 4 mg, 9 mg or 12 mg 80-week double-blind trial Pre-specified extension to 104 weeks in participants with BMI 35 Weight loss results at 80 weeks: 4 mg: -19.0% (~47 lbs / 21.4 kg) 9 mg: -25.9% (~64 lbs / 29.2 kg) 12 mg: -28.3% (~70 lbs / 31.9 kg) That degree of weight loss approaches levels traditionally associated with bariatric surgery

however, these assessments are subject to variability and placebo effects